Meeting
2023 ASCO Annual Meeting
Vulnerability to immune therapy in BRAF- and MYB-altered pediatric gliomas.
Authors
Michael DeCuypere
Ann and Robert H Lurie Children’s Hospital, Chicago, IL
Michael DeCuypere , Melissa LoPresti , Hinda Najem , Shashwat Tripathi , Joanne Xiu , Hilary Seifert , Valerie I. Brown , Giselle Y. López , Theodore Nicolaides , Craig M. Horbinski , Amy B. Heimberger
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Primary CNS Tumors–Glioma
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 2066)
DOI
10.1200/JCO.2023.41.16_suppl.2066
Abstract #
2066
Poster Bd #
423
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Characterization of NY-ESO-1 gene expression in gastric cancer (GC).
First Author: Annika Lenz
Poster
2024 ASCO Breakthrough
Effect of heterozygosity loss of HLA-I on immune evasion and promotion of non-small cell lung cancer brain metastasis and immunotherapy resistance.
First Author: Jiefei Han
Poster
2024 ASCO Genitourinary Cancers Symposium
The immune characteristic analysis of BAP1 mutated clear cell renal cell carcinoma.
First Author: Zilin Wang
Poster
2024 ASCO Genitourinary Cancers Symposium
Alterations in tumor immune microenvironment and progressive immune exhaustion with advancing penile squamous cell carcinoma using multiplex immunofluorescence and image analysis.
First Author: Keerthi Gullapalli